BlueOcean Ventures

About The Fund

BlueOcean Ventures is a venture capital firm with a focus on equity investments in early-stage companies. They are headquartered in Geneva, Switzerland, and have an additional office in Saint Helier, United Kingdom. Their primary investment emphasis is on medical device and diagnostics companies during their early stages, with a particular interest in opportunities within Switzerland and Europe. A secondary focus extends to startups in life sciences, digital health, and nanotechnologies. The firm is distinctly positioned due to the extensive experience of their four founders - Faris Sabeti, Emmanuel de Watteville, Sacha Haymoz, and Thomas Zehnder - who bring a wealth of knowledge in building, managing, and coaching startups, further supporting their portfolio companies through a broad network of experts and industry contacts. Their advisory team consists of seasoned entrepreneurs and executives with diverse backgrounds across healthcare, technology, and executive leadership. BlueOcean Ventures not only specializes in seeding startups but also assists in their early stage development. Outside of healthcare, their interests also include companies operating in software, IT, CleanTech, and nanotechnology. Their approach is unique, as demonstrated by the launch of an Initial Coin Offering in Q4 2017 to harness blockchain and tokenization for venture capital. They engage in a comprehensive strategy that includes startup financing guidance, M&A expertise, and even involvement in patent litigation. BlueOcean Ventures leverages partnerships with leading institutions and associations such as SECA, Startup Invest, Fongit, P&TS, Ocorian, EPFL, ETHZ, and VentureLab to provide optimum support and resources for their investments.